Vicarious Surgical Inc.

RBOT OTC CIK: 0001812173

Company Information

Industry Orthopedic, Prosthetic & Surgical Appliances & Supplies
SIC Code 3842
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 78 FOURTH AVENUE, WALTHAM, MA, 02451
Mailing Address 78 FOURTH AVENUE, WALTHAM, MA, 02451
Phone (617) 868-1700
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

$97.97M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
DEF 14A Definitive proxy statement March 23, 2026 View on SEC
10-K Annual financial report March 9, 2026 View on SEC
8-K Current report of material events March 9, 2026 View on SEC
8-K Current report of material events March 6, 2026 View on SEC
8-K Current report of material events March 4, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
8-K Current report of material events February 2, 2026 View on SEC
8-K Current report of material events January 9, 2026 View on SEC
424B5 Prospectus supplement December 22, 2025 View on SEC

Annual Reports

10-K March 9, 2026
  • Develops the Vicarious Surgical System, an innovative single-port surgical robot with "human-like motion" and nine degrees of freedom.
  • Aims to revolutionize minimally invasive surgery by enhancing precision, improving surgeon ergonomics, and reducing healthcare costs.
View Analysis

Material Events

8-K Financial Distress March 4, 2026
High Impact
  • Strategic pivot to focus all resources on advancing the Gen 1 robot towards regulatory approval and market launch.
  • Implementation of workforce reductions to conserve capital and extend the company's cash runway.
View Analysis

Insider Trading

SELL 2 insiders 4 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3842)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.